Randall B. Sunberg

Counseling clients ranging from biotech startups to multinational pharmaceutical companies, Randall B. Sunberg structures and negotiates complex collaborations, mergers and acquisitions, divestitures, joint ventures, and corporate partnering and licensing transactions, as well as equity investments and royalty monetization transactions. In addition to pharma, biotech, medical device, diagnostics, and technology companies, Randy advises private equity, venture capital, and investment banking firms. He is co-leader of the firm’s life sciences interdisciplinary group and leader of the life sciences transactions practice.

Randy counsels on alternative financing arrangements such as royalty monetizations. He also handles technical contractual arrangements for drug discovery, development, manufacturing and supply, marketing and co-promotion, and outsourcing in the life sciences industry. Additionally, he advises boards of directors and significant shareholders on disclosure issues, corporate communications policies, and fiduciary duty matters. He serves clients throughout Europe and Asia, and across the United States.

Because of his global life sciences work, Randy is often asked to speak at industry events worldwide. He has spoken on such topics as mergers and acquisitions, strategic alliances, and licensing and collaboration transactions in the United States at Allicense, BIO and LES annual meetings; in Canada at BIOMedex; and in China at BIOForum; as well as at other life sciences–related conferences. He has also been a guest lecturer at the Rutgers Business School MBA Biotechnology Commercialization Concentration.

Back to FinTech Speakers »

Subscribe to our newsletter
to stay informed:

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

CONTACT US

Potential Sponsor? Speaker? Questions? Get in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.